ADMA Biologics Ownership | Who Owns ADMA Biologics?


OverviewForecastRevenueFinancialsChartTranscripts

ADMA Biologics Ownership Summary


ADMA Biologics is owned by 86.71% institutional investors, 1.97% insiders, and 11.32% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.25% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.08% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockADMA Biologics86.71%1.97%11.32%
SectorHealthcare Stocks 244.37%12.11%-156.48%
IndustryBiotech Stocks 379.01%11.75%-290.76%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de38.36M16.25%$321.04M
Vanguard group20.85M8.74%$380.39M
Blackrock18.64M8.15%$208.45M
State street17.12M7.25%$143.26M
Vanguard capital management10.10M4.28%$84.57M
Rubric capital management lp9.34M3.96%$78.17M
Capital research global investors8.76M3.71%$73.29M
First trust advisors lp7.80M3.30%$65.27M
Geode capital management6.06M2.57%$50.73M
Caligan partners lp5.73M2.43%$47.92M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
B group3.26M12.82%$27.31M
Stonepine capital management740.00K2.90%$6.19M
Ophir asset management pty1.26M2.27%$18.40M
Caligan partners lp5.73M2.25%$47.92M
Oberweis asset management inc/2.71M1.52%$39.76M
First light asset management1.07M1.48%$15.67M
Velan capital investment management lp250.00K1.27%$2.09M
Ranger investment management2.12M1.12%$17.71M
Mesirow institutional investment management782.45K1.03%$13.42M
Marathon capital management532.35K0.90%$4.46M

Top Buyers

HolderShares% AssetsChange
Rubric capital management lp9.34M0.72%7.53M
First trust advisors lp7.80M0.04%7.44M
D. e. shaw5.27M0.02%4.71M
State street17.12M0.00%3.03M
Nantahala capital management2.36M0.66%2.36M

Top Sellers

HolderShares% AssetsChange
Sachem head capital management lp---11.38M
Westfield capital management co lp---6.99M
American century companies226.52K0.00%-4.56M
Citadel advisors1.37M0.00%-4.44M
Janus henderson group98.26K0.00%-3.84M

New Positions

HolderShares% AssetsChangeValue
Nantahala capital management2.36M0.66%2.36M$19.75M
Sixth street partners management company2.09M0.00%2.09M$17.52M
Healthcare of ontario pension plan trust fund667.00K0.01%667.00K$5.58M
Ruffer llp422.96K0.13%422.96K$3.54M
Ashford capital management361.50K0.40%361.50K$3.26M

Sold Out

HolderChange
Tfc financial management-1.00
Dunhill financial-1.00
Ameritas advisory services-1.00
Curio wealth-3.00
Mendota financial group-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026337-9.65%204,710,306-3.37%861.08%143-28.50%14625.86%
Mar 31, 2026318-14.29%181,408,566-17.67%760.89%166-17.82%106-10.92%
Dec 31, 2025122-68.06%37,183,315-83.04%150.19%65-60.37%34-78.48%
Sep 30, 2025154-58.93%47,734,498-76.76%190.27%60-74.36%68-33.98%
Jun 30, 20253764.16%204,872,1710.17%841.15%23018.56%107-6.96%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF14.12M6.08%9.36K
First Trust NYSE Arca Biotech ETF10.02M4.31%-91.48K
American Funds SMALLCAP World A8.52M3.67%-1.76M
State Street® SPDR® S&P® Biotech ETF7.65M3.29%17.57K
Vanguard MStar Total Stk Mkt Idx Invest7.05M3.15%27.10K
Vanguard Morn Total Stk Mkt Idx Investor7.03M3.02%-158.62K
Vanguard Total Stock Mkt Idx Inv7.03M3.02%-158.62K
Vanguard US Total Market Shares ETF7.15M3.01%281.42K
iShares Russell 2000 ETF5.86M2.52%-104.06K
American Century Small Cap Growth Inv3.36M1.45%200.08K

Recent Insider Transactions


DateNameRoleActivityValue
May 27, 2026Grossman Jerrold B-Buy$50.62K
May 12, 2026Grossman Jerrold B-Buy$100.13K
May 11, 2026Grossman Jerrold B-Buy$100.13K
Mar 16, 2026Grossman Adam S President and CEOSell$227.40K
Mar 16, 2026Grossman Adam S President and CEOSell$90.96K

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q23-
2026 Q125
2025 Q4-6
2025 Q3-6

ADMA Ownership FAQ


Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 86.71%, followed by 1.97% insiders and 11.32% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 379.01%, which ADMA Biologics falls below.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock funding, inc. /de (38.36M shares, 16.25%), Vanguard group (20.85M shares, 8.74%), and Blackrock (18.64M shares, 8.15%). Together, they hold 33.13% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

B group is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 12.82% of its assets in 3.26M ADMA Biologics shares, valued at 27.31M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 6.08% of its total shares outstanding invested in 14.12M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools